Emdactilin 150
Solution for injection
Composition
Spectinomycini hydrochloridum pentahydratum eq. 100 mg Spectinomyci¬num Lincomycini hydrochloridum monohy¬dratum eq. 50 mg Lincomycinum Excipients q.s. ad 1 ml.
Pharmacotherapeutic category
Antibacterial for systemic use (combination of lincomycin + spectinomycin)
Properties
Lincomycin and spectinomycin act by inhibition of the microbial protein synthesis at different levels of ribosomes. The combination is active against Gram-positive and Gram-negative bacteria, anaerobes and mycoplasmas. Synergism has been demonstrated against a number of microorganisms (e.g. certain mycoplasmas).
Indications
For the treatment of infections caused by lincomycin / spectinomycin susceptible micro-organisms.
Dosage, route and method of administration
IM injection: 15 mg of active substances per kg BW or 1 ml of Emdactilin 150 per 10 kg BW, once daily for 1 – 7 days (Duration depends on animal species and indication). In calves, this dosage can be given twice the first day.
Shelf-life
2 years.
Packaging
Vials of 100 ml or 250 ml.
Carton with 1, 6 or 12 vials.
The trade name and/or the specifications of the product (target animal species, indications, dosage and administration, precautions and warnings, etc.) may differ from country to country. Please contact us for further information.